Nasal Polyps clinical trials

Explore recruiting nasal polyps clinical trials.

Recruiting nasal polyps studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Nasal Polyps trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis (CRS) in Adults

Hungary, Belgium, Germany, Bulgaria, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Poland, Denmark, France, Romania, Netherlands, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Sweden, Portugal, Germany, Poland, Hungary, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: PREDICTUMAB, an open-label, controlled, randomized multinational pragmatic trial.

Belgium, France

Therapeutic use (Phase IV) EU CTIS Study details

A randomized Phase 2, double-blind, placebo-controlled, parallel-group, 2-arm study to assess the efficacy, safety, and tolerability of subcutaneous lunsekimig in adult participants with chronic rhinosinusitis with nasal polyps (CRSwNP)

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Nasal Polyps trials by city

Nasal Polyps in Toronto Nasal Polyps in Vancouver Nasal Polyps in Montreal Nasal Polyps in Calgary Nasal Polyps in Edmonton Nasal Polyps in Ottawa Nasal Polyps in Winnipeg Nasal Polyps in Quebec City Nasal Polyps in Hamilton Nasal Polyps in Kitchener Nasal Polyps in London Nasal Polyps in Halifax Nasal Polyps in New York Nasal Polyps in Los Angeles Nasal Polyps in Chicago Nasal Polyps in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease